Risk factors of extended-spectrum beta-lactamaseproducing Enterobacteriaceae bacteremia in Thai emergency department: a retrospective case-control study

1. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34:1589-96.10.1097/01.CCM.0000217961.75225.E916625125Open DOISearch in Google Scholar

2. Dellinger RP, Levy MM, Carlet JM, Surviving Sepsis Campaign Management Guidelines Committee. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36:296-327.10.1097/01.CCM.0000298158.12101.4118158437Open DOISearch in Google Scholar

3. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J ClinMicrobiol Infect Dis. 2004; 23:163-7.10.1007/s10096-003-1084-214986159Open DOISearch in Google Scholar

4. Rodriguez-Bano J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajad JP, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med. 2008;168:1897-902.10.1001/archinte.168.17.189718809817Open DOISearch in Google Scholar

5. Mirelis B, Navarro F, Miro E, Mesa RJ, Coll P, Prats G. Community transmission of extended-spectrum betalactamase. Emerg Infect Dis. 2003; 9:1024-5.10.3201/eid0908.030094302061212971376Open DOISearch in Google Scholar

6. Yilmaz E, Akalin H, Ozbey S, Kordan Y, Sinirtaș M, Gürcüoglu E, et al. Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J Chemother. 2008; 20:581-5.10.1179/joc.2008.20.5.58119028620Open DOISearch in Google Scholar

7. Ling TK, Xiong J, Yu Y, Lee CC, Ye H, Hawkey PM. Multicenter antimicrobial susceptibility survey ofgram-negative bacteria isolated from patients with community-acquired infections in the People’s Republic of China. Antimicrob Agents Chemother. 2006; 50:41-67.10.1128/AAC.50.1.374-378.2006134678916377716Search in Google Scholar

8. Kang CI, Cheong HS, Chung DR, Peck KR, Song JH, Oh MD, et al. Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Eur J Clin Microbiol Infect Dis. 2008; 27:85-8.10.1007/s10096-007-0401-617943331Open DOISearch in Google Scholar

9. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control. 2007; 35:606-12.10.1016/j.ajic.2007.05.00817980240Open DOISearch in Google Scholar

10. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000; 31(Suppl 4):S131-810.1086/31407911017862Open DOISearch in Google Scholar

11. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcome in the ICU setting. Chest. 2000; 118:146-55.10.1378/chest.118.1.146Open DOISearch in Google Scholar

12. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect. 2007; 55:254-9.10.1016/j.jinf.2007.04.007Open DOISearch in Google Scholar

13. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001; 32:1162-71.10.1086/319757Open DOISearch in Google Scholar

14. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia:Churchill Livingston; 2009, p. 957-85.10.1016/B978-0-443-06839-3.00069-2Search in Google Scholar

15. Donowitz GR. Pleuropulmonary and bronchial infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingston; 2009, p. 891-916.Search in Google Scholar

16. Sifri CD, Madoff LC. Intra-abdominal infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia:Churchill Livingston; 2009, p. 1035-44.Search in Google Scholar

17. Pasternack MS, Swartz MN. Skin and soft tissue infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingston; 2009, p. 1289-312.Search in Google Scholar

18. CLSI (NCCLS). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, M100-S18. Vol. 28. Wayne:Clinical Laboratory Standards Institute; 2008.Search in Google Scholar

19. Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996; 48:907-16.10.1016/0895-4356(96)00025-XOpen DOISearch in Google Scholar

20. Chayakulkeeree M, Junsriwong P, Keerasuntonpong A, Tribuddharat C, Thamlikitkul V. Epidemiology of extended-spectrum beta-lactamaseproducing gramnegative bacilli at Siriraj Hospital, Thailand, 2003. Southeast Asian J Trop Med Public Health. 2005; 36:1503-9.Search in Google Scholar

21. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Predictors of mortality among patients with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. Infect Control Hosp Epidemiol. 2008;29:80-2.10.1086/52432118171194Search in Google Scholar

22. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 2004;39:31-7.10.1086/42081615206050Open DOISearch in Google Scholar

23. Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentn C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009;49:682-90.10.1086/60471319622043Open DOISearch in Google Scholar

24. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother. 2006; 57:780-3.10.1093/jac/dkl03516492721Search in Google Scholar

25. Martinez JA, Aguilar J, Almela M, Marco F, Soriano A, López F, et al. Prior use of carbapenems may be a significant risk factor for extended-spectrum betalactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. J Antimicrob Chemother. 2006;58:1082-5.10.1093/jac/dkl36716950822Search in Google Scholar

26. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791-7.10.7326/0003-4819-137-10-200211190-0000712435215Open DOISearch in Google Scholar

27. Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Ruíz M, Peña C, et al. Spanish network for research in infectious diseases (REIPI). Community-onset bacteremia due to extended-spectrum beta-lactamaseproducing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010; 50:40-8.10.1086/64953719995215Open DOISearch in Google Scholar

28. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis. 2001; 32:1055-61.10.1086/31960011264034Open DOISearch in Google Scholar

29. Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis. 2002; 34:1558-63.10.1086/34053312032889Open DOISearch in Google Scholar

30. Behar PR, Teixeira PJ, Fachel JM, Kalil AC. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamaseproducing Klebsiella pneumoniae infections. A prospective controlled study. J Hosp Infect. 2008; 68:123-9.10.1016/j.jhin.2007.10.02218192077Open DOISearch in Google Scholar

31. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterialcystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999; 29:745-58.10.1086/52042710589881Open DOISearch in Google Scholar

32. Dow G, Rao P, Harding G, Brunka J, Kennedy J, Alfa M, et al. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis. 2004; 39:658-64.10.1086/42300015356779Open DOISearch in Google Scholar

33. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiellapneumoniae isolates causing bacteremia. Clin Infect Dis. 2000; 30:473-8.10.1086/31371910722430Open DOISearch in Google Scholar

34. Oktem IM, Gulay Z, Bicmen M, Gur D. HITIT Project Study Group. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey. Jpn J Infect Dis. 2008; 61:13-7.Search in Google Scholar

35. LavillaS, Gonzalez-Lopez JJ, Sabate M, Garcia-Fernandez A, Larrosa MN, Bartolome RM, et al. Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. J Antimicrob Chemother. 2008; 61:291-5. 10.1093/jac/dkm44818029415Search in Google Scholar